Neurocrine Biosciences Announces Webcast to Present Year-End Financial Results and Company Update
SAN DIEGO, Jan. 29 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report year-end 2001 financial results on Tuesday, February 5, 2002. Neurocrine will also be hosting a Webcast to discuss its financial results and provide a company update on Tuesday, February 5, 2002 at 10:30 AM Eastern Standard Time (EST)/ 7:30 AM Pacific Standard Time (PST). Participants may access the Webcast through a link provided by PRNewswire at http://www.videonewswire.com/event.asp?id=3214 or alternatively through the Company's website at www.neurocrine.com
Gary A. Lyons, President and CEO of Neurocrine Biosciences and Paul W. Hawran, Executive Vice President and CFO will be presenting the financial results for year-end 2001 and the strategy for 2002. In addition, other members of Neurocrine's senior management team will provide an overview on Neurocrine's development program. If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Jones or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X32540072
SOURCE Neurocrine Biosciences, Inc.
Web site: http: //www.neurocrine.com
Audio: http: //www.videonewswire.com/event.asp?id=3214
CONTACT: Claudia Jones or Elizabeth Foster, of Neurocrine Biosciences, Inc., +1-858-658-7600